JP Morgan Chase’s Hinge Health HNGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$58.7M Sell
718,176
-86,255
-11% -$4.68M ﹤0.01% 1362
2026
Q1
$29.6M Buy
804,431
+13,516
+2% +$562K ﹤0.01% 1751
2025
Q4
$36.7M Buy
790,915
+46,859
+6% +$2.26M ﹤0.01% 1573
2025
Q3
$36.5M Sell
744,056
-103,089
-12% -$5.39M ﹤0.01% 1624
2025
Q2
$43.8M Buy
+847,145
New +$34.2M ﹤0.01% 1407

Other funds holding HNGE

JP Morgan Chase's HNGE Position: Q2 2026 in Review

JP Morgan Chase reduced its Hinge Health (HNGE) stake by 11% in Q2 2026, selling an estimated $4.68M and leaving 718,176 shares worth $58.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1362.

JP Morgan Chase first reported a position in HNGE in Q2 2025 and has held it in 5 quarters since. 277 funds tracked by Wall St. Rank hold HNGE as of Q2 2026.

  • JP Morgan Chase held 718,176 shares of Hinge Health worth $58.7M as of Q2 2026.
  • JP Morgan Chase sold 86,255 Hinge Health shares in Q2 2026, an estimated $4.68M.
  • Hinge Health made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #1362 holding.
  • JP Morgan Chase first reported a position in Hinge Health in Q2 2025 and has held it in 5 quarters since.
  • 277 funds tracked by Wall St. Rank held Hinge Health as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.